Fig. 5From: Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotateIHC staining for SSTR1–5 in CLB-BAR, CLB-GE and IMR-32. Tissues were stained with H&E prior to IHC staining for SSTR1–5. For positive control, tissue from human cerebellum was applied for SSTR1 and SSTR3–5, and tissue from human small intestinal NET was applied for SSTR2. Bar equals 50 μmBack to article page